Insight

Melissa Loh: Healthcare utilization in leukaemia and myelodysplastic syndrome

Melissa Loh/X

Dec 19, 2024, 11:23

Melissa Loh: Healthcare utilization in leukaemia and myelodysplastic syndrome

Melissa Loh, Associate Professor at the University of Rochester Medical Center, shared on X:

“Extension of our prior work on healthcare utilization in leukaemia and myelodysplastic syndrome, we now also showed high cost at EOL.

MOLST form completion associated with lower cost.”

Melissa Loh

Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes

Authors: Marissa LoCastro, Andrea M. Baran, Jane L. Liesveld, Eric Huselton, Michael W. Becker, Kristen Marie O’Dwyer, Omar S. Aljitawi, Megan Baumgart, Eric Snyder, Benzi Kluger, Kah Poh Loh, Jason H. Mendler

Melissa Loh

Andrea M. Baran Benzi Kluger cancer Eric Huselton Eric Snyder healthcare utilization Jane L. Liesveld Jason H. Mendler Kah Poh Loh Kristen Marie O’Dwyer leukaemia Marissa LoCastro Megan Baumgart Melissa Loh Michael W. Becker Myelodysplastic syndrome Omar S. Aljitawi OncoDaily Oncology

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage